Home » MYLAN ANNOUNCES FINAL APPROVAL FOR BISOPROLOL FUMARATE TABLETS
MYLAN ANNOUNCES FINAL APPROVAL FOR BISOPROLOL FUMARATE TABLETS
Mylan Laboratories has received final FDA approval for its abbreviated new drug application for bisoprolol fumarate in 5- and 10-mg tablets. The product is the generic equivalent of Duramed Pharmaceuticals' beta-blocker Zebeta.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May